Terminated PHASE4 INTERVENTIONAL 2-arm NCT01776203

Study of a Progestin to Prevent Bleeding Associated With Initiation of Medical Menopause With GnRH Agonist

Initiation of Medical Menopause With Depot Leuprolide Acetate vs Depot Leuprolide Acetate Plus Medroxyprogesterone Acetate: A Pilot Randomized

Sponsor: Kaiser Permanente

Conditions Dysfunctional Uterine Bleeding

Interventions Medroxyprogesterone 17-Acetate

Updated 5 times since 2017 Last updated: Mar 10, 2015 Started: Jan 31, 2012 Primary completion: Apr 30, 2014 Completion: Apr 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Inadequate enrollment

Other terminated trials from Kaiser Permanente

See all terminations from Kaiser Permanente

Listed as NCT01776203, this PHASE4 trial focuses on Dysfunctional Uterine Bleeding and remains terminated or withdrawn. Sponsored by Kaiser Permanente, it has been updated 5 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE4

First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kaiser Permanente

Data source: Kaiser Permanente

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Los Angeles, United States